Swierkosz TA - Search Results

1

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.

Herrmann HC, Swierkosz TA, Kapoor S, Tardiff DC, DiBattiste PM, Hirshfeld JW, Klugherz BD, Kolansky DM, Magness K, Valettas N, Wilensky RL. Herrmann HC, et al. Among authors: swierkosz ta. Am J Cardiol. 2002 Jun 1;89(11):1293-7. doi: 10.1016/s0002-9149(02)02329-9. Am J Cardiol. 2002. PMID: 12031731 Clinical Trial. No abstract available.

2

IIb or not IIb: when, how, and which GP IIb/IIIa inhibitor?

Swierkosz TA, Valettas N, Herrmann HC. Swierkosz TA, et al. Catheter Cardiovasc Interv. 2001 Apr;52(4):433-4. doi: 10.1002/ccd.1097. Catheter Cardiovasc Interv. 2001. PMID: 11285594 No abstract available.

3

Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.

Swierkosz TA, Jordan L, McBride M, McGough K, Devlin J, Botting RM. Swierkosz TA, et al. Med Sci Monit. 2002 Dec;8(12):BR496-503. Med Sci Monit. 2002. PMID: 12503027

4

Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Swierkosz TA, et al. Br J Pharmacol. 1995 Apr;114(7):1335-42. doi: 10.1111/j.1476-5381.1995.tb13353.x. Br J Pharmacol. 1995. PMID: 7541688 Free PMC article.

5

Relationship between different isoforms of nitric oxide synthase and cyclooxygenase in various cell types.

Swierkosz TA, Mitchell JA, Tomlinson A, Botting RM, Warner TD, Vane JR. Swierkosz TA, et al. Pol J Pharmacol. 1994 Nov-Dec;46(6):587-92. Pol J Pharmacol. 1994. PMID: 7542521

6

Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.

Zembowicz A, Swierkosz TA, Southan GJ, Hecker M, Vane JR. Zembowicz A, et al. Among authors: swierkosz ta. Br J Pharmacol. 1992 Dec;107(4):1001-7. doi: 10.1111/j.1476-5381.1992.tb13398.x. Br J Pharmacol. 1992. PMID: 1281716 Free PMC article.

7

Mechanisms of the endothelium-dependent relaxation induced by NG-hydroxy-L-arginine.

Zembowicz A, Swierkosz TA, Southan GJ, Hecker M, Gryglewski RJ, Vane JR. Zembowicz A, et al. Among authors: swierkosz ta. J Cardiovasc Pharmacol. 1992;20 Suppl 12:S57-9. doi: 10.1097/00005344-199204002-00017. J Cardiovasc Pharmacol. 1992. PMID: 1282987

8

L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta.

Swierkosz TA, Mitchell JA, Sessa WC, Hecker M, Vane JR. Swierkosz TA, et al. Biochem Biophys Res Commun. 1990 Oct 15;172(1):143-8. doi: 10.1016/s0006-291x(05)80184-6. Biochem Biophys Res Commun. 1990. PMID: 2222463

9

Inhibition by L-glutamine of the release of endothelium-derived relaxing factor from cultured endothelial cells.

Hecker M, Mitchell JA, Swierkosz TA, Sessa WC, Vane JR. Hecker M, et al. Among authors: swierkosz ta. Br J Pharmacol. 1990 Oct;101(2):237-9. doi: 10.1111/j.1476-5381.1990.tb12693.x. Br J Pharmacol. 1990. PMID: 2257431 Free PMC article.

10

Vasorelaxant and platelet-suppressant potencies of four NO-donors.

Zembowicz A, Dudek RD, Radziszewski W, Swierkosz TA, Trybulec M, Gryglewski RJ. Zembowicz A, et al. Among authors: swierkosz ta. Pol J Pharmacol Pharm. 1990 May-Jun;42(3):275-81. Pol J Pharmacol Pharm. 1990. PMID: 2124687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters